Implantable Drug Delivery Devices Market Analysis

The implantable drug delivery devices market is segmented on the basis of products into contraceptive implants, spinal implants, brachytherapy seeds, drug-eluting stents, bio-absorbable stents, intraocular implants, infusion pumps, and others, out of which, the drug-eluting stents segment is expected to dominate the global market during the forecast period, in terms of revenue, on account of increasing implementations of these implants in the medical industry for various indications such as cancer treatment, contraception, hormone regulation, and others.

Based on type, the biodegradable products segment is expected to witness significant growth over the forecast period in the market on the back of the its advantages over non-biodegradable products, which includes easy absorption, fabrication, and excretion of inter-polymers, greater acceptance rate, positive outcome, and others.

Our in-depth analysis of the global market includes the following segments:

Product	Contraceptive Implants Spinal Implants Brachytherapy Seeds Drug-eluting Stents Bio-absorbable Stents Intraocular Implants Infusion Pumps Others
Type	Biodegradable Non-biodegradable
Application	Contraception Ophthalmology Cardiovascular Diabetes Oncology Auto-immune Diseases Others
End-User	Hospitals Ambulatory Surgical Centers (ASCs) Others

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of implantable drug delivery devices is assessed at USD 28.95 billion.

Implantable Drug Delivery Devices Market size was over USD 27.15 billion in 2023 and is projected to exceed USD 76.55 billion by 2036, growing at over 8.3% CAGR during the forecast period i.e., between 2024-2036. Emergence of novel products and increasing incidence of chronic diseases will fuel the market growth.

Asia Pacific is likely to account for largest revenue share by 2036, on account of steadily increasing healthcare expenditure and rising concern & awareness for the development of advanced devices in the region.

The major players in the market include Boston Scientific Corporation, Merck & Co., Inc., Medtronic Plc, Allergan, Inc., Abbott Laboratories, DSM Biomedical, Varian Medical Systems, Inc., and others.

Implantable Drug Delivery Devices Market Analysis